Central memory and effector memory T cell subsets: Function, generation, and maintenance

Annual Review of Immunology

Volumn 22, Issue , 2004, Pages 745-763

  Sallusto, Federica ^a   Geginat, Jens ^a   Lanzavecchia, Antonio ^a  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

Author keywords

Chemokine receptors; Effector function; Lymphocyte migration; T lymphocyte activation; TH1 TH2

Indexed keywords

CD27 ANTIGEN; CD28 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR5; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 7; PERFORIN;

ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CELL HETEROGENEITY; CELL INTERACTION; CELL TYPE; CENTRAL MEMORY T CELL; CROSS REACTION; CYTOKINE PRODUCTION; DENDRITIC CELL; DNA METHYLATION; EFFECTOR CELL; EFFECTOR MEMORY T CELL; HOMEOSTASIS; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL MONITORING; IMMUNOSTIMULATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MEMORY CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; HUMANS; IMMUNOLOGIC MEMORY; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS;

EID: 2142730100     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.22.012703.104702     Document Type: Review

References (121)

1. Manz RA, Thiel A, Radbruch A. 1997. Lifetime of plasma cells in the bone marrow. Nature 388:133-34
2. Slifka MK, Antia R, Whitmire JK, Ahmed R. 1998. Humoral immunity due to long-lived plasma cells. Immunity 8:363-72
3. Ochsenbein AF, Pinschewer DD, Sierro S, Horvath E, Hengartner H, Zinkernagel RM. 2000. Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs. Proc. Natl. Acad. Sci. USA 97:13263-68
4. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708-12
5. Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK. 2001. Visualizing the generation of memory CD4 T cells in the whole body. Nature 410:101-5
6. Masopust D, Vezys V, Marzo AL, Lefrancois L. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291:2413-17
7. Lanzavecchia A, Sallusto F. 2000. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 290:92-97
8. Campbell JJ, Bowman EP, Murphy K, Youngman KR, Siani MA, et al. 1998. 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7. J. Cell Biol. 141:1053-59
9. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, et al. 1999. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99:23-33
10. Campbell JJ, Murphy KE, Kunkel EJ, Brightling CE, Soler D, et al. 2001. CCR7 expression and memory T cell diversity in humans. J. Immunol. 166:877-84
11. Champagne P, Ogg GS, King AS, Knabenhans C, Ellefsen K, et al. 2001. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410:106-11
12. Dunbar PR, Smith CL, Chao D, Salio M, Shepherd D, et al. 2000. A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response. J. Immunol. 165:6644-52
13. Valmori D, Scheibenbogen C, Dutoit V, Nagorsen D, Asemissen AM, et al. 2002. Circulating tumor-reactive CD8+ T cells in melanoma patients contain a CD45RA+CCR7 - effector subset exerting ex vivo tumor-specific cytolytic activity. Cancer Res. 62:1743-50
14. Hislop AD, Annels NE, Gudgeon NH, Leese AM, Rickinson AB. 2002. Epitope-specific evolution of human CD8+ T cell responses from primary to persistent phases of Epstein-Barr virus infection. J. Exp. Med. 195:893-905
15. Baron V, Bouneaud C, Cumano A, Lim A, Arstila TP, et al. 2003. The repertoires of circulating human CD8+ central and effector memory T cell subsets are largely distinct. Immunity 18:193-204
16. Hamann D, Baars PA, Rep MH, Hooibrink B, Kerkhof-Garde SR, et al. 1997. Phenotypic and functional separation of memory and effector human CD8+ T cells. J. Exp. Med. 186:1407-18
17. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, et al. 2002. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8:379-85
18. Rufer N, Zippelius A, Batard P, Pittet MJ, Kurth I, et al. 2003. Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions. Blood 102:1779-87
19. Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, Williams LT. 1998. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 391:799-803
20. Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B. 1998. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J. Exp. Med. 187:655-60
21. Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, et al. 2000. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J. Exp. Med. 192:1545-52
22. Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, Moser B. 2000. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J. Exp. Med. 192:1553-62
23. Kim CH, Rott LS, Clark-Lewis I, Campbell DJ, Wu L, Butcher EC. 2001. Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells. J. Exp. Med. 193:1373-81
24. Sallusto F, Lanzavecchia A, Mackay CR. 1998. Chemokines and chemokine receptors in T-cell priming and Th1/Th2- mediated responses. Immunol. Today 19:568-74
25. Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, et al. 1998. CCR5 is characteristic of Th1 lymphocytes. Nature 391:344-45
26. Kim CH, Kunkel EJ, Boisvert J, Johnston B, Campbell JJ, et al. 2001. Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J. Clin. Invest. 107:595-601
27. Sallusto F, Mackay CR, Lanzavecchia A. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277:2005-7
28. Nagata K, Tanaka K, Ogawa K, Kemmotsu K, Imai T, et al. 1999. Selective expression of a novel surface molecule by human Th2 cells in vivo. J. Immunol. 162:1278-86
29. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, et al. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187:129-34
30. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:875-83
31. Butcher EC, Picker LJ. 1996. Lymphocyte homing and homeostasis. Science 272:60-66
32. von Andrian UH, Mackay CR. 2000. T-cell function and migration. Two sides of the same coin. N. Engl. J. Med. 343:1020-34
33. Campbell JJ, Haraldsen G, Pan J, Rottman J, Qin S, et al. 1999. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400:776-80
34. Zabel BA, Agace WW, Campbell JJ, Heath HM, Parent D, et al. 1999. Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis. J. Exp. Med. 190:1241-56
35. Campbell JJ, Hedrick J, Zlotnik A, Siani MA, Thompson DA, Butcher EC. 1998. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 219:381-84
36. Middleton J, Neil S, Wintle J, Clark-Lewis I, Moore H, et al. 1997. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91:385-95
37. Stein JV, Rot A, Luo Y, Narasimhaswamy M, Nakano H, et al. 2000. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J. Exp. Med. 191:61-76
38. Sallusto F, Kremmer E, Palermo B, Hoy A, Ponath P, et al. 1999. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur. J. Immunol. 29:2037-45
39. Kishimoto TK, Jutila MA, Butcher EC. 1990. Identification of a human peripheral lymph node homing receptor: a rapidly down-regulated adhesion molecule. Proc. Natl. Acad. Sci. USA 87:2244-48
40. Chao CC, Jensen R, Dailey MO. 1997. Mechanisms of L-selectin regulation by activated T cells. J. Immunol. 159:1686-94
41. Geginat J, Lanzavecchia A, Sallusto F. 2003. Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 101:4260-66
42. Son NH, Murray S, Yanovski J, Hodes RJ, Weng N. 2000. Lineage-specific telomere shortening and unaltered capacity for telomerase expression in human T and B lymphocytes with age. J. Immunol. 165:1191-96
43. Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MA, et al. 1995. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3:87-98
44. H2 lymphocytes. Nat. Immunol. 4:78-86
45. Grogan JL, Mohrs M, Harmon B, Lacy DA, Sedat JW, Locksley RM. 2001. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 14:205-15
46. Gunzer M, Schafer A, Borgmann S, Grabbe S, Zanker KS, et al. 2000. Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential. Immunity 13:323-32
47. Harris NL, Watt V, Ronchese F, Le Gros G. 2002. Differential T cell function and fate in lymph node and nonlymphoid tissues. J. Exp. Med. 195:317-26
48. Yazdanbakhsh M, Kremsner PG, van Ree R. 2002. Allergy, parasites, and the hygiene hypothesis. Science 296:490-94
49. Michie CA, McLean A, Alcock C, Beverley PC. 1992. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature 360:264-65
50. Tough DF, Sprent J. 1994. Turnover of naive- and memory-phenotype T cells. J. Exp. Med. 179:1127-35
51. Seddon B, Tomlinson P, Zamoyska R. 2003. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat. Immunol. 4:680-86
52. Zhang X, Sun S, Hwang I, Tough DF, Sprent J. 1998. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8:591-99
53. Lodolce JP, Boone DL, Chai S, Swain RE, Dassopoulos T, et al. 1998. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9:669-76
54. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. 2000. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1:426-32
55. Unutmaz D, Pileri P, Abrignani S. 1994. Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J. Exp. Med. 180:1159-64
56. Geginat J, Sallusto F, Lanzavecchia A. 2001. Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4+ T cells. J. Exp. Med. 194:1711-19
57. Alves NL, Hooibrink B, Arosa FA, Van Lier RA. 2003. IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro. Blood 102:2541-46
58. Zheng W, Flavell RA. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89:587-96
59. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655-69
60. Mullen AC, High FA, Hutchins AS, Lee HW, Villarino AV, et al. 2001. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292:1907-10
61. Agarwal S, Rao A. 1998. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9:765-75
62. Takemoto N, Kamogawa Y, Jun-Lee H, Kurata H, Arai KI, et al. 2000. Cutting edge: chromatin remodeling at the IL-4/IL-13 intergenic regulatory region for Th2-specific cytokine gene cluster. J. Immunol. 165:6687-91
63. Lee GR, Fields PE, Flavell RA. 2001. Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level. Immunity 14:447-59
64. Iezzi G, Scotet E, Scheidegger D, Lanzavecchia A. 1999. The interplay between the duration of TCR and cytokine signaling determines T cell polarization. Eur. J. Immunol. 29:4092-101
65. Ansel KM, Lee DU, Rao A. 2003. An epigenetic view of helper T cell differentiation. Nat. Immunol. 4:616-23
66. Scotet E, Schroeder S, Lanzavecchia A. 2001. Molecular regulation of CC-chemokine receptor 3 expression in human T helper 2 cells. Blood 98:2568-70
67. Lu Q, Wu A, Ray D, Deng C, Attwood J, et al. 2003. DNA methylation and chromatin structure regulate T cell perforin gene expression. J. Immunol. 170:5124-32
68. Afkarian M, Sedy JR, Yang J, Jacobson NG, Cereb N, et al. 2002. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat. Immunol. 3:549-57
69. Sundrud MS, Grill SM, Ni D, Nagata K, Alkan SS, et al. 2003. Genetic reprogramming of primary human T cells reveals functional plasticity in Th cell differentiation. J. Immunol. 171:3542-49
70. Lee DU, Agarwal S, Rao A. 2002. Th2 lineage commitment and efficient IL-4 production involves extended demethylation of the IL-4 gene. Immunity 16:649-60
71. Barber DL, Wherry EJ, Ahmed R. 2003. Cutting edge: rapid in vivo killing by memory CD8 T cells. J. Immunol. 171:27-31
72. Sad S, Mosmann TR. 1994. Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J. Immunol. 153:3514-22
73. Gorelik L, Fields PE, Flavell RA. 2000. Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression. J. Immunol. 165:4773-77
74. Gorelik L, Constant S, Flavell RA. 2002. Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. J. Exp. Med. 195:1499-505
75. Valitutti S, Muller S, Cella M, Padovan E, Lanzavecchia A. 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375:148-51
76. Viola A, Schroeder S, Sakakibara Y, Lanzavecchia A. 1999. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 283:680-82
77. Iezzi G, Karjalainen K, Lanzavecchia A. 1998. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8:89-95
78. Stoll S, Delon J, Brotz TM, Germain RN. 2002. Dynamic imaging of T cell-dendritic cell interactions in lymph nodes. Science 296:1873-76
79. Iezzi G, Scheidegger D, Lanzavecchia A. 2001. Migration and function of antigen-primed nonpolarized T lymphocytes in vivo. J. Exp. Med. 193:987-93
80. Manjunath N, Shankar P, Wan J, Weninger W, Crowley MA, et al. 2001. Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J. Clin. Invest. 108:871-78
81. Weninger W, Crowley MA, Manjunath N, von Andrian UH. 2001. Migratory properties of naive, effector, and memory CD8+ T cells. J. Exp. Med. 194:953-36
82. Langenkamp A, Casorati G, Garavaglia C, Dellabona P, Lanzavecchia A, Sallusto F. 2002. T cell priming by dendritic cells: thresholds for proliferation, differentiation and death and intraclonal functional diversification. Eur. J. Immunol. 32:2046-54
83. Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, et al. 1999. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397:263-36
84. Coyle AJ, Lehar S, Lloyd C, Tian J, Delaney T, et al. 2000. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity 13:95-105
85. Kopf M, Coyle AJ, Schmitz N, Barner M, Oxenius A, et al. 2000. Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection. J. Exp. Med. 192:53-31
86. Diehl L, van Mierlo GJ, den Boer AT, van der Voort E, Fransen M, et al. 2002. In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway. J. Immunol. 168:3755-62
87. van Stipdonk MJ, Lemmens EE, Schoenberger SP. 2001. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol. 2:423-29
88. Gett AV, Sallusto F, Lanzavecchia A, Geginat J. 2003. T cell fitness determined by signal strength. Nat. Immunol. 4:355-60
89. van Stipdonk MJ, Hardenberg G, Bijker MS, Lemmens EE, Droin NM, et al. 2003. Dynamic programming of CD8+ T lymphocyte responses. Nat. Immunol. 4:361-65
90. Lanzavecchia A, Sallusto F. 2002. Opinion-decision making in the immune system: progressive differentiation and selection of the fittest in the immune response. Nat. Rev. Immunol. 2:982-87
91. Langenkamp A, Messi M, Lanzavecchia A, Sallusto F. 2000. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 1:311-16
92. Kaech SM, Hemby S, Kersh E, Ahmed R. 2002. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111:837-51
93. Lauvau G, Vijh S, Kong P, Horng T, Kerksiek K, et al. 2001. Priming of memory but not effector CD8 T cells by a killed bacterial vaccine. Science 294:1735-39
94. Wang X, Mosmann T. 2001. In vivo priming of CD4T cells that produce interleukin (IL)-2 but not IL-4 or interferon (IFN)-gamma, and can subsequently differentiate into IL-4 or IFN-gamma-secreting cells. J. Exp. Med. 194:1069-80
95. Kurts C, Kosaka H, Carbone FR, Miller JF, Heath WR. 1997. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8+ T cells. J. Exp. Med. 186:239-45
96. Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, et al. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:769-79
97. Hernandez J, Aung S, Redmond WL, Sherman LA. 2001. Phenotypic and functional analysis of CD8+ T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J. Exp. Med. 194:707-17
98. Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM. 2002. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196:1627-38
99. Hernandez J, Aung S, Marquardt K, Sherman LA. 2002. Uncoupling of proliferative potential and gain of effector function by CD8+ T cells responding to self-antigens. J. Exp. Med. 196:323-33
100. Busch DH, Kerksiek KM, Pamer EG. 2000. Differing roles of inflammation and antigen in T cell proliferation and memory generation. J. Immunol. 164:4063-70
101. Campbell DJ, Kim CH, Butcher EC. 2001. Separable effector T cell populations specialized for B cell help or tissue inflammation. Nat. Immunol. 2:876-81
102. Roman E, Miller E, Harmsen A, Wiley J, Von Andrian UH, et al. 2002. CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J. Exp. Med. 196:957-68
103. Turner SJ, Diaz G, Cross R, Doherty PC. 2003. Analysis of clonotype distribution and persistence for an influenza virus-specific CD8+ T cell response. Immunity 18:549-59
104. H1 cells have differential capacities for memory cell generation in vivo. Nat. Immunol. 3:852-58
105. Wherry EJ, Teichgraber V, Becker TC, Masopust D, Kaech SM, et al. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4:225-34
106. Seder RA, Ahmed R. 2003. Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat. Immunol. 4:835-42
107. Langenkamp A, Nagata K, Murphy K, Wu L, Lanzavecchia A, Sallusto F. 2003. Kinetics and expression patterns of chemokine receptors in human CD4+ T lymphocytes primed by myeloid or plasmacytoid dendritic cells. Eur. J. Immunol. 33:474-82
108. Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, Schoenberger SP. 2003. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421:852-56
109. Sun JC, Bevan MJ. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300:339-42
110. Shedlock DJ, Shen H. 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300:337-39
111. Ridge JP, Di Rosa F, Matzinger P. 1998. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393:474-78
112. Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480-83
113. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478-80
114. Bourgeois C, Rocha B, Tanchot C. 2002. A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory. Science 297:2060-63
115. Maxwell JR, Campbell JD, Kim CH, Vella AT. 1999. CD40 activation boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying peripheral T cell deletion. J. Immunol. 162:2024-34
116. Maxwell JR, Weinberg A, Prell RA, Vella AT. 2000. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion. J. Immunol. 164:107-12
117. Hendriks J, Gravestein LA, Tesselaar K, van Lier RA, Schumacher TN, Borst J. 2000. CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 1:433-40
118. Fearon DT, Manders P, Wagner SD. 2001. Arrested differentiation, the self-renewing memory lymphocyte, and vaccination. Science 293:248-50
119. Bernasconi NL, Traggiai E, Lanzavecchia A. 2002. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298:2199-202
120. Dudley ME, Rosenberg SA. 2003. Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat. Rev. Cancer 3:666-75
121. Welsh RM, Selin LK. 2002. No one is naive: the significance of heterologous T-cell immunity. Nat. Rev. Immunol. 2:417-26